| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 07/06/2000 | WO2000039083A2 Pyrazole compounds and uses thereof |
| 07/06/2000 | WO2000039077A2 Thyroid receptor ligands |
| 07/06/2000 | WO2000039070A1 Ortho-diphenol compounds, methods and pharmaceutical compositions for inhibiting parp |
| 07/06/2000 | WO2000038786A2 Use of cyclooxygenase 2 inhibitor and an integrin antagonist as a combination therapy in the treatment of neoplasia |
| 07/06/2000 | WO2000038785A2 Methods for treating certain diseases using naaladase inhibitors |
| 07/06/2000 | WO2000038747A2 Absorbent article composition and method of use for sequestering skin irritants |
| 07/06/2000 | WO2000038733A1 Peptidic product, process and composition |
| 07/06/2000 | WO2000038732A1 Hyaluronate lyase used for promoting penetration in topical agents |
| 07/06/2000 | WO2000038730A2 Use of a cyclooxygenase-2 inhibitor and one or more antineoplastic agents for combination therapy in neoplasia |
| 07/06/2000 | WO2000038719A1 Use of a matrix metalloproteinase inhibitor and an integrin antagonist in the treatment of neoplasia |
| 07/06/2000 | WO2000038718A2 Use of matrix metalloproteinase inhibitor together with an antineoplastic agents, optionally also together with radiation, in the treatment of neoplasia |
| 07/06/2000 | WO2000038717A2 Use of a matrix metalloproteinase inhibitor and radiation as a combined treatment of neoplasia |
| 07/06/2000 | WO2000038715A2 Use of an integrin antagonist and radiation in the treatment of neoplasia |
| 07/06/2000 | WO2000038713A1 Agonists or antagonists of cutaneous t cell-attracting chemokine (ctack) or vasoactive intestinal contractor (vic) chemokines |
| 07/06/2000 | WO2000038701A1 Use of unsaponifiable matters of vegetable oils for preparing a medicine |
| 07/06/2000 | WO2000038695A2 Aciclovir compositions containing dimethicone |
| 07/06/2000 | WO2000038676A1 Use of at-1 receptor antagonist or at-2 receptor modulator for treating diseases associated with an increase of at-1 or at-2 receptors |
| 07/06/2000 | WO2000038674A1 COMPOUNDS WHICH AFFECT mRNA STABILITY AND USES THEREFOR |
| 07/06/2000 | WO2000038665A2 Use of an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia |
| 07/06/2000 | WO2000038660A2 Use of bisphosphonates for the prevention and treatment of infectious processes |
| 07/06/2000 | WO2000038658A1 Spray-type cosmetic composition and matrix used in said composition for dermal administration |
| 07/06/2000 | WO2000038653A1 Improved formulation for topical non-invasive application in vivo |
| 07/06/2000 | WO2000038648A1 Cosmetic composition with depigmenting activity and use thereof |
| 07/06/2000 | WO2000038647A1 Skin protection agents containing a fragment mixture produced from hyaluronic acid by hydrolysis |
| 07/06/2000 | WO2000038646A1 Dermatological compositions containing tannic acid and a microbial proliferation inhibitor |
| 07/06/2000 | WO2000038626A2 Substrate composition and method of use for sequestration of skin irritants |
| 07/06/2000 | WO2000038625A2 Facial tissue composition and method of use for sequestration of nasal secretion skin irritants |
| 07/06/2000 | WO2000018352A3 A method for treating inflammatory diseases by administering a thrombin inhibitor |
| 07/06/2000 | WO2000017222A8 31 human secreted proteins |
| 07/06/2000 | WO2000015770A3 Human serine/threonine protein kinases |
| 07/06/2000 | WO2000011028A3 Anti-inflammatory peptides derived from il-2 and analogues thereof |
| 07/06/2000 | WO1999064035A9 β2-ADRENERGIC RECEPTOR AGONISTS |
| 07/06/2000 | WO1999052514A3 Pharmaceutical composition and combination preparation for immunosuppressive therapy |
| 07/06/2000 | DE19960633A1 Ointment for treating skin conditions |
| 07/06/2000 | CA2358315A1 Ortho-diphenol compounds, methods and pharmaceutical compositions for inhibiting parp |
| 07/06/2000 | CA2358094A1 Human fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2 |
| 07/06/2000 | CA2356929A1 Method of using a matrix metalloproteinase inhibitor and one or more antineoplastic agents as a combonation therapy in the treatment of neoplasia |
| 07/06/2000 | CA2356895A1 Aciclovir compositions containing dimethicone |
| 07/06/2000 | CA2356748A1 Method of using an integrin antagonist and radiation therapy as combination therapy in the treatment of neoplasia |
| 07/06/2000 | CA2356661A1 Agonists or antagonists of cutaneous t cell-attracting chemokine (ctack) or vasoactive intestinal contractor (vic) chemokines |
| 07/06/2000 | CA2356622A1 Compounds which affect mrna stability and uses therefor |
| 07/06/2000 | CA2356606A1 Method of using a cyclooxygenase-2 inhibitor and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia |
| 07/06/2000 | CA2356462A1 Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia |
| 07/06/2000 | CA2356459A1 Method of using a matrix metalloproteinase inhibitor and radiation therapy as combination therapy in the treatment of neoplasia |
| 07/06/2000 | CA2356402A1 Use of a matrix metalloproteinase inhibitor and an integrin antagonist in the treatment of neoplasia |
| 07/06/2000 | CA2356319A1 Thyroid receptor ligands |
| 07/06/2000 | CA2356302A1 Method of using a cyclooxygenase-2 inhibitor and an integrin antagonist as a combination therapy in the treatment of neoplasia |
| 07/06/2000 | CA2356262A1 Use of bisphosphonates for the prevention and treatment of infectious processes |
| 07/06/2000 | CA2356098A1 Use of unsaponifiable matters of vegetable oils for preparing a medicine |
| 07/06/2000 | CA2354052A1 Methods for treating certain diseases using naaladase inhibitors |
| 07/06/2000 | CA2352896A1 Pyrimidine compounds |
| 07/06/2000 | CA2351357A1 Use of at-1 receptor antagonist or at-2 receptor modulator for treating diseases associated with an increase of at-1 or at-2 receptors |
| 07/06/2000 | CA2350685A1 Spray-type cosmetic composition and matrix used in said composition for dermal administration |
| 07/06/2000 | CA2350589A1 3,3-biarylpiperidine and 2,2-biarylmorpholine derivatives |
| 07/06/2000 | CA2321672A1 Caspase-8 interacting proteins |
| 07/06/2000 | CA2293860A1 Cosmetic composition containing a styrene/acrylate copolymer and a fatty phase |
| 07/05/2000 | EP1016716A2 Dna encoding a growth factor specific for epithelial cells |
| 07/05/2000 | EP1016453A1 Nanoemulsion based on ethoxylated fatty ethers or ethoxylated fatty esters and uses thereof in the fields of cosmetics, dermatology and/or ophthalmology |
| 07/05/2000 | EP1015604A1 Human prl-1 phosphatase |
| 07/05/2000 | EP1015586A2 Tie receptor tyrosine kinase ligand homologues |
| 07/05/2000 | EP1015585A2 Tie ligand homologues |
| 07/05/2000 | EP1015572A2 Nuclear transfer with differentiated fetal and adult donor cells |
| 07/05/2000 | EP1015464A2 SYNTHETIC DIVALENT sLex CONTAINING POLYLACTOSAMINES AND METHODS FOR USE |
| 07/05/2000 | EP1015437A1 Benzoxazine and benzothiazine derivatives and their use in pharmaceuticals |
| 07/05/2000 | EP1015421A1 New phenylamidine derivatives, a process for preparing the same and their use as medicaments |
| 07/05/2000 | EP1015413A1 Anti-cancer compounds |
| 07/05/2000 | EP1015014A1 Methods and compositions for inhibiting angiogenesis |
| 07/05/2000 | EP1014998A1 Polymeric compositions |
| 07/05/2000 | EP1014976A1 Novel substituted imidazole compounds |
| 07/05/2000 | EP1014967A1 Use of zinc salts of conjugated linoleic acids to treat skin disorders |
| 07/05/2000 | EP1014937A1 Antimicrobial wipes |
| 07/05/2000 | EP1014934A1 Use of at least an extract of the genus chrysanthemum for stimulating skin and/or hair pigmentation |
| 07/05/2000 | EP1014927A1 Use of shogaols and gingerols for preparing deodorant compositions |
| 07/05/2000 | EP0726895B1 Pseudodipeptide product having an imidazole grouping and applications |
| 07/05/2000 | CN1259040A Compositions and methods for inhibiting photoaging of skin |
| 07/05/2000 | CN1258539A Burns and scalds treating medicine |
| 07/05/2000 | CN1258532A Medicated cosmetics capable of being used to treat primary and secondary varicose vein simultaneously and its preparation |
| 07/05/2000 | CN1258523A Wound healing oil and its preparation |
| 07/05/2000 | CN1258492A Amphoteric lipids dispersion body |
| 07/05/2000 | CN1258450A Natural plant disinfectant and its preparation |
| 07/05/2000 | CN1054071C Medicinal liquid for injury and its preparation |
| 07/05/2000 | CN1054069C Process for preparing plaster for treating burn and scald for external use |
| 07/05/2000 | CN1054067C Medicine for treatment of skin injury and preparation method thereof |
| 07/05/2000 | CN1054062C Traditional Chinese medicine preparation for curing burn and scald and its preparing method |
| 07/05/2000 | CN1054039C Skin health care beautifying cream |
| 07/04/2000 | US6084152 Method for producing transgenic cucumber that produces high levels of superoxide dismutase |
| 07/04/2000 | US6084095 Including 6-amino-4-(3-bromoanilino)pyrido(3,2-d)pyrimidine; 4-(3-bromoanilino)-6-methylaminopyrido (3,2-d)pyrimidine; and 4-(3-bromoanilino)-6-methylaminopyrido(3,2-d)pyrimidine; useful in treating proliferative diseases such as cancer |
| 07/04/2000 | US6084075 Agonist and antagonist antibodies to the chemokine receptor-2 (CCR2) |
| 07/04/2000 | US6083976 Reacting aloesin with a substituted or unsubsituted alkyl group containing a halogen leaving group in the presence of a base |
| 07/04/2000 | US6083956 Optically pure androgen mediator |
| 07/04/2000 | US6083930 Methods and compositions based on inhibition of cell invasion and fibrosis by anionic polymers |
| 07/04/2000 | US6083928 Applying topically to skin composition containing lipopolysaccharide extracted from klebsiella pneumoniae strain |
| 07/04/2000 | US6083926 Water soluble vitamin B12 receptor modulating agents and methods related thereto |
| 07/04/2000 | US6083910 Therapeutic uses of resolved intact or clipped native-sequence PDGF-BB dimers |
| 07/04/2000 | US6083904 Therapeutic and diagnostic methods and compositions based on notch proteins and nucleic acids |
| 07/04/2000 | US6083903 Boronic ester and acid compounds, synthesis and uses |
| 07/04/2000 | US6083723 Vector comprising regulatory nucleotide sequences and nucleic acids that code for a exogenous polypeptide |
| 06/29/2000 | WO2000037944A1 Kidney disease detection and treatment |
| 06/29/2000 | WO2000037639A2 Lymphocytic membrane proteins |
| 06/29/2000 | WO2000037502A2 Vascular endothelial cell growth factor antagonists and uses thereof |